• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种用于评估大鼠泪液中干眼疾病的多重电化学发光免疫分析方法。

Development and validation of a multiplex electrochemiluminescence immunoassay to evaluate dry eye disease in rat tear fluids.

机构信息

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, University of Antwerp, Campus Drie Eiken D.S.723, FFBD-FDFAR-LMPH, Universiteitsplein 1, 2610, Wilrijk, Antwerp, Belgium.

出版信息

Sci Rep. 2023 Jul 27;13(1):12203. doi: 10.1038/s41598-023-39397-8.

DOI:10.1038/s41598-023-39397-8
PMID:37500810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10374623/
Abstract

Dry eye disease (DED) is a challenge in ophthalmology. Rat models represent valuable tools to study the pathophysiology and to develop novel treatments. A major challenge in DED research is detecting multiple biomarkers in a low tear volume sample. Multiplex immunoassays for DED rat research are missing. We have developed a multiplex electrochemiluminescence immunoassay (ECLIA) to detect three biomarkers for DED: MMP-9, IL-17 and ICAM-1. Tears, used as matrix, were collected from six healthy Wistar rats. Assays were run based on the U-Plex Meso Scale Diagnostics (MSD) platform, by two independent operators according to the EMA guideline on bioanalytical method validation. Linear mixed, regression models were fit to perform the statistical analysis on the range of concentrations for the chosen analytes. During optimization, it has observed that incubation time, temperature and agitation affected the robustness of the protocol. ECLIA optimum conditions include the use of antibodies at 0.5 µg/ml concentration and 1 h incubation at room temperature with shaking. Precision met the acceptance criteria in the chosen range: 1062-133 pg/ml for ICAM-1, 275-34.4 pg/ml for IL-17, 1750-219 pg/ml for MMP-9. Accuracy and linearity were acceptable for a broader range. This is the first report of a validated ECLIA that allows measurements of three relevant DED biomarkers in rat tear fluids.

摘要

干眼症 (DED) 是眼科学的一个挑战。大鼠模型是研究病理生理学和开发新疗法的有价值的工具。DED 研究中的一个主要挑战是在低泪液量样本中检测多种生物标志物。用于 DED 大鼠研究的多重免疫分析方法仍然缺失。我们开发了一种用于检测 DED 的三种生物标志物的多重电化学发光免疫分析 (ECLIA):MMP-9、IL-17 和 ICAM-1。使用作为基质的眼泪,从六只健康的 Wistar 大鼠中收集。根据 U-Plex Meso Scale Diagnostics (MSD) 平台,由两名独立操作人员按照 EMA 生物分析方法验证指南运行检测。线性混合回归模型用于对所选分析物的浓度范围内进行统计分析。在优化过程中,观察到孵育时间、温度和搅拌会影响方案的稳健性。ECLIA 的最佳条件包括使用 0.5µg/ml 浓度的抗体和在室温下孵育 1 小时并搅拌。在所选范围内精度符合验收标准:ICAM-1 为 1062-133pg/ml,IL-17 为 275-34.4pg/ml,MMP-9 为 1750-219pg/ml。更广泛范围内的准确性和线性度是可以接受的。这是首次报道一种经过验证的 ECLIA,可用于测量大鼠泪液中的三种相关 DED 生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/c9f64601ade1/41598_2023_39397_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/3d640a377f25/41598_2023_39397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/c892d9a61a5a/41598_2023_39397_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/258eac0a083e/41598_2023_39397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/5e3b8f296c5b/41598_2023_39397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/acddd6c3bc98/41598_2023_39397_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/879b5105777a/41598_2023_39397_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/11ca9b2a3d72/41598_2023_39397_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/837a425ed1ec/41598_2023_39397_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/10b2e38debd4/41598_2023_39397_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/c9f64601ade1/41598_2023_39397_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/3d640a377f25/41598_2023_39397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/c892d9a61a5a/41598_2023_39397_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/258eac0a083e/41598_2023_39397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/5e3b8f296c5b/41598_2023_39397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/acddd6c3bc98/41598_2023_39397_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/879b5105777a/41598_2023_39397_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/11ca9b2a3d72/41598_2023_39397_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/837a425ed1ec/41598_2023_39397_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/10b2e38debd4/41598_2023_39397_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebb7/10374623/c9f64601ade1/41598_2023_39397_Fig10_HTML.jpg

相似文献

1
Development and validation of a multiplex electrochemiluminescence immunoassay to evaluate dry eye disease in rat tear fluids.开发和验证一种用于评估大鼠泪液中干眼疾病的多重电化学发光免疫分析方法。
Sci Rep. 2023 Jul 27;13(1):12203. doi: 10.1038/s41598-023-39397-8.
2
Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.使用市售即时免疫检测法在干燥性眼病中检测基质金属蛋白酶 9。
Ophthalmology. 2016 Nov;123(11):2300-2308. doi: 10.1016/j.ophtha.2016.07.028. Epub 2016 Sep 21.
3
Dichotomous versus 5-scale grading system for the interpretation of the point-of-care immunoassay for tear matrix metalloproteinase-9 in dry eye.用于解读眼表基质金属蛋白酶-9 点检测免疫分析的二分类与 5 级分级系统在干眼中的应用。
Sci Rep. 2023 Apr 13;13(1):6085. doi: 10.1038/s41598-023-32928-3.
4
Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.干眼病情进展(PROOF)自然史研究的研究设计与基线研究结果
BMC Ophthalmol. 2017 Dec 28;17(1):265. doi: 10.1186/s12886-017-0646-5.
5
Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.干眼症疾病临床严重程度与泪液细胞因子、趋化因子和可溶性受体的相关性。
Invest Ophthalmol Vis Sci. 2012 Aug 13;53(9):5443-50. doi: 10.1167/iovs.11-9417.
6
Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.在一组非干眼患者中,泪膜渗透压及两种不同基质金属蛋白酶-9(MMP-9)检测与常见干眼检测的相关性
Cornea. 2015 Jul;34(7):739-44. doi: 10.1097/ICO.0000000000000449.
7
Optimization and validation of an existing, surgical and robust dry eye rat model for the evaluation of therapeutic compounds.优化并验证一种现有的、用于评估治疗性化合物的手术性且稳定的干眼大鼠模型。
Exp Eye Res. 2016 May;146:172-178. doi: 10.1016/j.exer.2016.03.006. Epub 2016 Mar 17.
8
Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.干燥性眼疾的严重程度、治疗和活动性泪液生物标志物:来自 III 期临床试验的分析。
Ocul Surf. 2018 Jul;16(3):368-376. doi: 10.1016/j.jtos.2018.05.001. Epub 2018 May 14.
9
The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.良性特发性眼睑痉挛对干眼症和眼表炎症的影响。
Am J Ophthalmol. 2014 Mar;157(3):591-7.e1-2. doi: 10.1016/j.ajo.2013.11.014. Epub 2013 Nov 20.
10
Effect of maqui-berry extract in dry eye disease - A clinical and molecular analysis.蓝莓提取物对干眼症的影响——临床和分子分析。
Indian J Ophthalmol. 2023 Apr;71(4):1613-1618. doi: 10.4103/IJO.IJO_2909_22.

本文引用的文献

1
Sensitivity and performance of three novel quantitative assays of SARS-CoV-2 nucleoprotein in blood.三种新型 SARS-CoV-2 核衣壳蛋白血淸定量检测方法的敏感性和性能。
Sci Rep. 2023 Feb 17;13(1):2868. doi: 10.1038/s41598-023-29973-3.
2
A Novel Ferroptosis Inhibitor UAMC-3203, a Potential Treatment for Corneal Epithelial Wound.一种新型铁死亡抑制剂UAMC-3203,有望用于治疗角膜上皮损伤。
Pharmaceutics. 2022 Dec 29;15(1):118. doi: 10.3390/pharmaceutics15010118.
3
The Potential Role of Regulated Cell Death in Dry Eye Diseases and Ocular Surface Dysfunction.
调控细胞死亡在干眼疾病和眼表面功能障碍中的潜在作用。
Int J Mol Sci. 2023 Jan 1;24(1):731. doi: 10.3390/ijms24010731.
4
Application Effect and Accuracy Analysis of Electrochemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Serological Test of Hepatitis B Virus.电化学发光免疫分析法与酶联免疫吸附测定法在乙型肝炎病毒血清学检测中的应用效果及准确性分析
Evid Based Complement Alternat Med. 2022 Aug 4;2022:9371497. doi: 10.1155/2022/9371497. eCollection 2022.
5
Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2.快速生成内部血清学检测方法与商业试剂盒相当,这对大流行的早期应对至关重要:以SARS-CoV-2为例
Front Med (Lausanne). 2022 May 6;9:864972. doi: 10.3389/fmed.2022.864972. eCollection 2022.
6
Animal models of dry eye disease: Useful, varied and evolving (Review).干眼症的动物模型:有用、多样且不断发展(综述)
Exp Ther Med. 2021 Dec;22(6):1394. doi: 10.3892/etm.2021.10830. Epub 2021 Oct 1.
7
Performance of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients: A retrospective study in outbreak on a cruise ship.无症状或轻症 COVID-19 患者中抗 SARS-CoV-2 抗体检测的性能:一艘游轮暴发疫情的回顾性研究。
PLoS One. 2021 Sep 28;16(9):e0257452. doi: 10.1371/journal.pone.0257452. eCollection 2021.
8
Autoimmunity in dry eye disease - An updated review of evidence on effector and memory Th17 cells in disease pathogenicity.干燥性眼疾中的自身免疫 - 对效应器和记忆性 Th17 细胞在疾病发病机制中作用的证据的最新综述。
Autoimmun Rev. 2021 Nov;20(11):102933. doi: 10.1016/j.autrev.2021.102933. Epub 2021 Sep 9.
9
Cytokines: From Clinical Significance to Quantification.细胞因子:从临床意义到定量分析。
Adv Sci (Weinh). 2021 Aug;8(15):e2004433. doi: 10.1002/advs.202004433. Epub 2021 Jun 10.
10
Experimental Pharmacotherapy for Dry Eye Disease: A Review.干眼症的实验性药物治疗:综述
J Exp Pharmacol. 2021 Mar 23;13:345-358. doi: 10.2147/JEP.S237487. eCollection 2021.